Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
In recent years, and even more since its legalization in several jurisdictions, cannabis and the endocannabinoid system have received an increasing amount of interest related to their potential exploitation in clinical settings. Cannabinoids have been suggested and shown to be effective in the treatment of various conditions. In cancer, the endocannabinoid system is altered in numerous types of tumours and can relate to cancer prognosis and disease outcome. Additionally, cannabinoids display anticancer effects in several models by suppressing the proliferation, migration and/or invasion of cancer cells, as well as tumour angiogenesis. However, the therapeutic use of cannabinoids is currently limited to the treatment of symptoms and pain associated with chemotherapy, while their potential use as cytotoxic drugs in chemotherapy still requires validation in patients. Along with cannabinoids, cannabis contains several other compounds that have also been shown to exert anti-tumorigenic actions. The potential anti-cancer effects of cannabinoids, terpenes and flavonoids, present in cannabis, are explored in this literature review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · cited 1×
“During the development of Western Medicine, a progressive understanding of cannabis properties led to wider medical and recreational consumption in the 20th century until the use of this plant became marginalized and criminalized, largely due to misinformation, which greatly impacted progress regarding the understandi…”
BackgroundKaempferol: A Key Emphasis to Its Anticancer Potential
Imran, M., Salehi, B., Sharifi-Rad, J., Aslam Gondal, T., Saeed, F., Imran, A., Shahbaz, M., Tsouh Fokou, P. V., Umair Arshad, M., Khan, H., et al. (2019) · Molecules · doi:10.3390/molecules24122277 · Cited by 819 · cited 1×
“[328] provides extensive information about the anticancer effects of luteolin in many cancers including breast, prostate, oral, lung, kidney, cervical, placental, ovarian, skin, liver, esophageal, bladder and glioblastoma.”
BackgroundA phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Tavsan, Z., & Kayali, H. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109004 · Cited by 190
Beyond THC and Endocannabinoids
Pacher, P., Kogan, N. M., & Mechoulam, R. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021441 · Cited by 175
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Holland, M. L., Panetta, J. A., Hoskins, J. M., Bebawy, M., Roufogalis, B. D., Allen, J. D., & Arnold, J. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.033 · Cited by 157
The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids
Holland, M. L., Lau, D. T. T., Allen, J. D., & Arnold, J. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707467 · Cited by 150
Biosynthesis of cannflavins A and B from Cannabis sativa L.
Rea, K. A., Casaretto, J. A., Al-Abdul-Wahid, M. S., Sukumaran, A., Geddes-McAlister, J., Rothstein, S. J., & Akhtar, T. A. (2019) · Phytochemistry · doi:10.1016/j.phytochem.2019.05.009 · Cited by 112 · cited 1×
“Cannflavins A and B are formed by a derivative of luteolin, chrysoeriol [427].”
BackgroundSantiago, M., Sachdev, S., Arnold, J. C., McGregor, I. S., & Connor, M. (2019) · Cannabis & Cannabinoid Research · doi:10.1089/can.2019.0016 · Cited by 112 · cited 1×
“However, since the reading used involved potassium channels in this study, it remains possible that some of the terpenoids tested could act through other CB1 or CB2-dependent signaling pathways that do not involve potassium channels or simply act through other molecular targets [449].”
BackgroundCannabinoids and terpenes as chemotaxonomic markers in cannabis.
Fischedick J, E. S. (2015) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000181 · Cited by 109
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
Finlay, D. B., Sircombe, K. J., Nimick, M., Jones, C., & Glass, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00359 · Cited by 99 · cited 1×
“In one study, it was shown that none of the five terpenes tested (myrcene, α- and β- pinene, β-caryophyllene, and limonene; either alone or in mixtures) had direct interactions with CB1 or CB2 receptors [448].”
BackgroundLi, Q., Wei, L., Lin, S., Chen, Y., Lin, J., & Peng, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10296 · Cited by 79 · cited 2×
“[351] looked at the potential of combining 5-fluorouracil (5-FU) with kaempferol in colorectal cancer.”
BackgroundQuercetin-Mediated Apoptosis and Cellular Senescence in Human Colon Cancer
Özsoy, S., Becer, E., Kabadayı, H., Vatansever, H. S., & Yücecan, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200408082026 · Cited by 62
Ambrož, M., Šmatová, M., Šadibolová, M., Pospíšilová, E., Hadravská, P., Kašparová, M., Skarková, V. H., Králová, V., & Skálová, L. (2019) · Acta Pharmaceutica · doi:10.2478/acph-2019-0003 · Cited by 52
Cited by
Flavonoids: A Myth or a Reality for Cancer Therapy?
Forni, C., Rossi, M., Borromeo, I., Feriotto, G., Platamone, G., Tabolacci, C., Mischiati, C., & Beninati, S. (2021) · Molecules · doi:10.3390/molecules26123583 · Cited by 79
Kobus, Z., Pecyna, A., Buczaj, A., Krzywicka, M., Przywara, A., & Nadulski, R. (2022) · Applied Sciences · doi:10.3390/app12136747 · Cited by 39
Metadata
- Authors
- Tomko, A. M., Whynot, E. G., Ellis, L. D., & Dupré, D. J.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-07-21
- Volume
- 12
- Issue
- 7
- Pages
- 1985
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3045475100
- Cited by
- 230
- References
- 15
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.